Zoledronate in the prevention of Pagetâs (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1 -mediated Pagetâs disease of bone
Cronin, Owen, Forsyth, Laura, Goodman, Kirsteen, Lewis, Steff C, Keerie, Catriona, Walker, Allan, Porteous, Mary, Cetnarskyj, Roseanne, Ranganath, Lakshminarayan R, Selby, Peter L, Hampson, Geeta, ChaVolume:
9
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2019-030689
Date:
September, 2019
File:
PDF, 615 KB
2019